There will be a depletion of the only US-licensed yellow fever vaccine available for US travelers by mid-2017, according to the CDC. Sanofi Pasteur will work with the CDC and the Food and
addiction Administration to allow importation of an alternative yellow fever vaccine manufactured by Sanofi Pasteur France. American supplies of yellow fever vaccine are expected to run out this summer, the Centers for Disease Control and Prevention said Friday, and it released a report outlining a plan to ensure continuous access. The global stockpile usually contains 6 million doses of the yellow fever vaccine, but that supply has become depleted due to recent outbreaks, according to the WHO. Symptoms of yellow fever usually begin three to six days after a bite from an infected mosquito and last about three or four days.
CDC working to keep yellow fever vaccine supply from running out
Health officials are now working with the supplier Sanofi Pasteur and the FDA to make another yellow fever vaccine available. This is a vast reduction from the estimated 4,000 sites that normally provide the yellow fever vaccine. However, an estimated 8 million U.S. residents traveled to 42 countries with endemic yellow fever virus transmission in 2015, according to the CDC. We are making every effort to see that yellow fever vaccination continues in the U.S. during this YF-VAX vaccine supply disruption." Sanofi Pasteur recognizes the challenge this supply disruption will cause for customers and for patients in need of yellow fever vaccine.
collected by :
Lucy William
No comments:
Post a Comment